hydrogen sulfide has been researched along with Cardiovascular Diseases in 72 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) remains unclear." | 9.12 | Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link? ( Deharo, P; Fromonot, J; Guieu, R; Marlinge, M; Mottola, G; Paganelli, F; Ruf, J, 2021) |
| "Hydrogen sulfide (H2 S) has traditionally been viewed as a highly toxic gas; however, recent studies have implicated H2 S as a third member of the gasotransmitter family, exhibiting properties similar to NO and carbon monoxide." | 6.52 | Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. ( Ferro, A; Ji, Y; Ma, Y; Meng, G; Xie, L, 2015) |
| " H2S therapy can also restore eNOS function and NO bioavailability and attenuate the pathological changes in the liver in L-NAME-induced hypertensive rats." | 5.40 | Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway. ( Dai, J; Duan, X; Ji, W; Jiang, X; Liu, S; Wu, Y; Yang, T, 2014) |
| "The influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) remains unclear." | 5.12 | Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link? ( Deharo, P; Fromonot, J; Guieu, R; Marlinge, M; Mottola, G; Paganelli, F; Ruf, J, 2021) |
| "DNA-based sensors can detect disease biomarkers, including acetone and ethanol for diabetes and H2S for cardiovascular diseases." | 3.83 | Ranking of Molecular Biomarker Interaction with Targeted DNA Nucleobases via Full Atomistic Molecular Dynamics. ( Cranford, SW; Wang, ML; Zhang, W, 2016) |
| "Hydrogen sulfide plays a significant part in anti-oxidative stress, which may participate in the general mechanism of ferroptosis and regulate it by some signaling molecules." | 3.01 | Ferroptosis and Hydrogen Sulfide in Cardiovascular Disease. ( Gui, DD; Jiang, ZS; Luo, W; Ma, Y; Ren, Z; Wu, ZF; Yan, BJ, 2023) |
| "Cardiovascular diseases are recognized to be a major cause of people morbidity and mortality." | 2.66 | Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology. ( Bian, JS; Cao, L; Huang, DJ; Nie, XW; Sun, HJ; Sun, MT; Wu, ZY; Zhu, MY, 2020) |
| "Hydrogen sulfide (H2S) is a signaling gasotransmitter, involved in different physiological and pathological processes." | 2.53 | Biochemistry and therapeutic potential of hydrogen sulfide - reality or fantasy? ( Brodek, P; Olas, B, 2016) |
| "Hydrogen sulfide (H2 S) has traditionally been viewed as a highly toxic gas; however, recent studies have implicated H2 S as a third member of the gasotransmitter family, exhibiting properties similar to NO and carbon monoxide." | 2.52 | Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. ( Ferro, A; Ji, Y; Ma, Y; Meng, G; Xie, L, 2015) |
| "Hydrogen sulfide (H2S) is a well-known toxic gas with the characteristic smell of rotten eggs." | 2.50 | Hydrogen sulfide as a potent cardiovascular protective agent. ( Cayabyab, FS; Chen, ZW; Cui, LB; Tang, CK; Wu, K; Yu, XH; Zheng, XL, 2014) |
| "Hydrogen sulfide (H(2)S) has traditionally been considered a toxic environmental pollutant." | 2.48 | Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? ( Gong, QH; Liu, XH; Pan, LL; Yang, HB; Zhu, YZ, 2012) |
| "Hydrogen sulfide (H(2)S) has been found to play an important role as a signal molecule in regulating cell survival." | 2.47 | Hydrogen sulfide in cell survival: a double-edged sword. ( Yang, G, 2011) |
| " Nitrates that have been used for over a century and nebivolol, a third-generation b-blocker with vasodilating properties by increasing bioavailability of NO, provide convincing arguments that the compounds acting via NO pathway will remain an important class of cardiovascular drugs." | 2.46 | [The role of nitric oxide, hydrogen sulfide and carbon monoxide in the regulation of the circulatory system and their pharmacotherapeutic potential]. ( Ufnal, M; Żera, T, 2010) |
| "Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases." | 2.43 | [A new strategy to treat hyperhomocysteinemia]. ( Chang, L; Du, JB; Geng, B; Tang, CS, 2005) |
| "Hydrogen Sulfide has been found to be produced endogenously in amounts that cause vasodilatation." | 2.43 | Endogenous hydrogen sulfide and the cardiovascular system-what's the smell all about? ( Pearson, RJ; Wang, R; Wilson, T, 2006) |
| "Hydrogen sulfide has emerged as an important gaseous signaling molecule and a regulator of critical biological processes." | 1.56 | Reactive Sulfur Species: A New Redox Player in Cardiovascular Pathophysiology. ( Kevil, CG; Kolluru, GK; Shen, X, 2020) |
| "Hydrogen sulfide also plays an important role in promoting resolution of inflammation, and restoration of normal tissue function." | 1.42 | Anti-inflammatory and cytoprotective properties of hydrogen sulfide. ( Gemici, B; Wallace, JL, 2015) |
| " H2S therapy can also restore eNOS function and NO bioavailability and attenuate the pathological changes in the liver in L-NAME-induced hypertensive rats." | 1.40 | Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway. ( Dai, J; Duan, X; Ji, W; Jiang, X; Liu, S; Wu, Y; Yang, T, 2014) |
| "Hydrogen sulfide (H2S) has been implicated in regulating cardiovascular pathophysiology in experimental models." | 1.39 | Plasma free H2S levels are elevated in patients with cardiovascular disease. ( Akkus, NI; Glawe, JD; Kevil, CG; Pardue, S; Peter, EA; Reddy, P; Shah, SH; Shen, X; Varma, J; Zhang, WW, 2013) |
| " Endogenous H2S bioavailability is regulated by several enzymes involved in the biosynthesis of cysteine." | 1.35 | Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetes. ( Lefer, DJ, 2008) |
| "Hydrogen sulfide has recently been considered to have an important role as a gasotransmitter in the cardiovascular system as well as in the central nervous system, but its action seems directly related to the presence of nitric oxide/nitric oxide-derivatives." | 1.35 | Hydrogen sulfide induces nitric oxide release from nitrite. ( Grossi, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.39) | 18.7374 |
| 1990's | 1 (1.39) | 18.2507 |
| 2000's | 10 (13.89) | 29.6817 |
| 2010's | 42 (58.33) | 24.3611 |
| 2020's | 18 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, W | 1 |
| Guo, W | 1 |
| Zheng, Y | 2 |
| Leitão, R | 1 |
| de Oliveira, GV | 1 |
| Rezende, C | 1 |
| Volino-Souza, M | 1 |
| Mesquita, J | 1 |
| de Carvalho, LL | 1 |
| Alvares, TS | 1 |
| Zhang, H | 1 |
| Du, J | 2 |
| Huang, Y | 1 |
| Tang, C | 2 |
| Jin, H | 2 |
| Wu, ZF | 1 |
| Yan, BJ | 2 |
| Luo, W | 2 |
| Gui, DD | 2 |
| Ren, Z | 2 |
| Ma, Y | 2 |
| Jiang, ZS | 2 |
| Huerta de la Cruz, S | 1 |
| Santiago-Castañeda, CL | 1 |
| Rodríguez-Palma, EJ | 1 |
| Medina-Terol, GJ | 1 |
| López-Preza, FI | 1 |
| Rocha, L | 1 |
| Sánchez-López, A | 1 |
| Freeman, K | 1 |
| Centurión, D | 1 |
| Ma, JS | 1 |
| Chen, J | 1 |
| Huang, H | 1 |
| Islam, MZ | 1 |
| Shackelford, RE | 1 |
| Nuvolone, D | 1 |
| Petri, D | 1 |
| Biggeri, A | 1 |
| Barbone, F | 1 |
| Voller, F | 1 |
| Peng, LJ | 1 |
| Wei, DH | 1 |
| Liu, LS | 1 |
| Zhang, DW | 1 |
| Di Giovanni, E | 1 |
| Buonvino, S | 1 |
| Amelio, I | 1 |
| Melino, S | 1 |
| Kolluru, GK | 3 |
| Shen, X | 4 |
| Kevil, CG | 5 |
| Sun, HJ | 1 |
| Wu, ZY | 1 |
| Cao, L | 2 |
| Zhu, MY | 1 |
| Nie, XW | 1 |
| Huang, DJ | 1 |
| Sun, MT | 1 |
| Bian, JS | 2 |
| Chen, Y | 1 |
| Zhang, F | 1 |
| Yin, J | 2 |
| Wu, S | 1 |
| Zhou, X | 1 |
| Teoh, JP | 1 |
| Li, X | 2 |
| Simoncini, T | 1 |
| Zhu, D | 1 |
| Fu, X | 1 |
| Paganelli, F | 1 |
| Mottola, G | 1 |
| Fromonot, J | 1 |
| Marlinge, M | 1 |
| Deharo, P | 1 |
| Guieu, R | 1 |
| Ruf, J | 1 |
| Wang, YZ | 1 |
| Ngowi, EE | 1 |
| Wang, D | 2 |
| Qi, HW | 1 |
| Jing, MR | 1 |
| Zhang, YX | 1 |
| Cai, CB | 1 |
| He, QL | 1 |
| Khattak, S | 1 |
| Khan, NH | 1 |
| Jiang, QY | 1 |
| Ji, XY | 1 |
| Wu, DD | 1 |
| Ding, Q | 1 |
| Zhu, YZ | 5 |
| Zhu, J | 1 |
| Yang, G | 2 |
| Wallace, JL | 2 |
| Vaughan, D | 1 |
| Dicay, M | 1 |
| MacNaughton, WK | 1 |
| de Nucci, G | 1 |
| Yu, W | 1 |
| Zhang, Z | 1 |
| Mistry, RK | 1 |
| Brewer, AC | 1 |
| Kenessary, D | 1 |
| Kenessary, A | 1 |
| Kenessariyev, UI | 1 |
| Juszkiewicz, K | 1 |
| Amrin, MK | 1 |
| Erzhanova, AE | 1 |
| Kanagy, NL | 1 |
| Cao, X | 1 |
| Wu, Z | 1 |
| Xiong, S | 1 |
| Sethi, G | 1 |
| Rajpal, S | 1 |
| Katikaneni, P | 1 |
| Deshotels, M | 1 |
| Pardue, S | 2 |
| Glawe, J | 2 |
| Akkus, N | 1 |
| Modi, K | 1 |
| Bhandari, R | 1 |
| Dominic, P | 1 |
| Reddy, P | 2 |
| Lin, Z | 1 |
| Altaf, N | 1 |
| Li, C | 1 |
| Chen, M | 1 |
| Pan, L | 1 |
| Xie, L | 2 |
| Fu, H | 1 |
| Han, Y | 1 |
| Ji, Y | 2 |
| Wang, XL | 1 |
| Wang, ZY | 1 |
| Guo, XQ | 1 |
| Zhang, YH | 1 |
| Pan, LL | 2 |
| Liu, XH | 2 |
| Wen, YD | 1 |
| Wang, H | 1 |
| Dyson, RM | 1 |
| Palliser, HK | 1 |
| Wilding, N | 1 |
| Kelly, MA | 1 |
| Chwatko, G | 1 |
| Glowacki, R | 1 |
| Berry, MJ | 1 |
| Ni, X | 1 |
| Wright, IMR | 1 |
| Li, Z | 1 |
| Polhemus, DJ | 2 |
| Lefer, DJ | 5 |
| Jin, L | 1 |
| Yu, Y | 1 |
| Esse, R | 1 |
| Barroso, M | 1 |
| Tavares de Almeida, I | 1 |
| Castro, R | 1 |
| Rajendran, S | 1 |
| Peter, EA | 1 |
| Shah, SH | 1 |
| Glawe, JD | 1 |
| Zhang, WW | 1 |
| Akkus, NI | 1 |
| Varma, J | 1 |
| Song, P | 1 |
| Zou, MH | 1 |
| Yu, XH | 1 |
| Cui, LB | 1 |
| Wu, K | 1 |
| Zheng, XL | 1 |
| Cayabyab, FS | 1 |
| Chen, ZW | 1 |
| Tang, CK | 1 |
| Meng, G | 1 |
| Ferro, A | 1 |
| Ji, W | 1 |
| Liu, S | 1 |
| Dai, J | 1 |
| Yang, T | 1 |
| Jiang, X | 1 |
| Duan, X | 1 |
| Wu, Y | 1 |
| Tian, H | 1 |
| Lewis, RJ | 1 |
| Copley, GB | 1 |
| Gemici, B | 1 |
| Wu, D | 1 |
| Hu, Q | 1 |
| Ma, F | 1 |
| Zhang, W | 1 |
| Wang, ML | 1 |
| Cranford, SW | 1 |
| Hackfort, BT | 1 |
| Mishra, PK | 1 |
| Brodek, P | 1 |
| Olas, B | 1 |
| Tomasova, L | 1 |
| Konopelski, P | 1 |
| Ufnal, M | 2 |
| Bazer, FW | 1 |
| Gao, H | 1 |
| Jobgen, W | 1 |
| Johnson, GA | 1 |
| Li, P | 1 |
| McKnight, JR | 1 |
| Satterfield, MC | 1 |
| Spencer, TE | 1 |
| Wu, G | 1 |
| Wang, XB | 2 |
| Jin, HF | 5 |
| Tang, CS | 6 |
| Du, JB | 7 |
| Grossi, L | 1 |
| Predmore, BL | 1 |
| Perna, AF | 1 |
| Luciano, MG | 1 |
| Ingrosso, D | 1 |
| Raiola, I | 1 |
| Pulzella, P | 1 |
| Sepe, I | 1 |
| Lanza, D | 1 |
| Violetti, E | 1 |
| Capasso, R | 1 |
| Lombardi, C | 1 |
| De Santo, NG | 1 |
| Lavu, M | 1 |
| Bhushan, S | 1 |
| Hart, JL | 1 |
| Gong, QH | 1 |
| Yang, HB | 1 |
| Żera, T | 1 |
| Skovgaard, N | 1 |
| Gouliaev, A | 1 |
| Aalling, M | 1 |
| Simonsen, U | 1 |
| Chen, S | 1 |
| Epelman, S | 1 |
| Tang, WH | 1 |
| KAIPAINEN, WJ | 1 |
| Moore, PK | 1 |
| Bhatia, M | 1 |
| Moochhala, S | 1 |
| Geng, B | 2 |
| Yan, H | 1 |
| Zhong, GZ | 1 |
| Zhang, CY | 1 |
| Chen, XB | 1 |
| Jiang, HF | 1 |
| Chang, L | 1 |
| Pearson, RJ | 1 |
| Wilson, T | 1 |
| Wang, R | 1 |
| Szabó, C | 1 |
| Jäppinen, P | 1 |
| Tola, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Aged Garlic on Vascular Function and Muscle Oxygenation Responses in the Elderly[NCT04008693] | 28 participants (Actual) | Interventional | 2019-08-26 | Completed | |||
| Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Twin Cities of Pakistan[NCT05011032] | 0 participants (Actual) | Interventional | 2021-08-12 | Withdrawn (stopped due to Ethical approval was not done. Hence the funding was withhold.) | |||
| Plasma Measurement of Hydrogen Sulfide, Nitric Oxide and Stress Hyperglycemia in Acute Myocardial Infarction[NCT03829605] | 50 participants (Anticipated) | Observational | 2019-02-15 | Not yet recruiting | |||
| Hydrogen Sulfide and Peripheral Arterial Disease[NCT01407172] | 252 participants (Actual) | Observational | 2011-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
43 reviews available for hydrogen sulfide and Cardiovascular Diseases
| Article | Year |
|---|---|
Recent Development of Hydrogen Sulfide Therapeutics in the Treatment of Cardiovascular Diseases.
Topics: Animals; Cardiovascular Diseases; Gasotransmitters; Humans; Hydrogen Sulfide; Prodrugs | 2021 |
Hydrogen Sulfide Regulates Macrophage Function in Cardiovascular Diseases.
Topics: Cardiovascular Diseases; Cystathionine gamma-Lyase; Gasotransmitters; Humans; Hydrogen Sulfide; Macr | 2023 |
Ferroptosis and Hydrogen Sulfide in Cardiovascular Disease.
Topics: Cardiovascular Diseases; Cell Death; Ferroptosis; Heart; Humans; Hydrogen Sulfide; Lipid Peroxidatio | 2023 |
Targeting hydrogen sulfide and nitric oxide to repair cardiovascular injury after trauma.
Topics: Cardiovascular Diseases; Cardiovascular System; Gasotransmitters; Humans; Hydrogen Sulfide; Nitric O | 2022 |
[Role and mechanism of hydrogen sulfide in vascular calcification].
Topics: Animals; Antioxidants; Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Mammals; | 2022 |
Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases.
Topics: Animals; Apoptosis; Autophagy; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System | 2020 |
Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Humans; Hydrogen Sul | 2020 |
Protective mechanisms of hydrogen sulfide in myocardial ischemia.
Topics: Animals; Cardiovascular Diseases; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Mitochondria; | 2020 |
Estrogen-Mediated Gaseous Signaling Molecules in Cardiovascular Disease.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Estrogens; Female; Gasotransmitters; Humans; Hydr | 2020 |
Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Rece | 2021 |
The Potential of Hydrogen Sulfide Donors in Treating Cardiovascular Diseases.
Topics: Administration, Inhalation; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cell Movement; | 2021 |
H
Topics: Animals; Cardiovascular Diseases; Extracellular Matrix; Gasotransmitters; Humans; Hydrogen Sulfide | 2021 |
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.
Topics: Animals; Arthritis; Captopril; Cardiovascular Agents; Cardiovascular Diseases; Dose-Response Relatio | 2018 |
Sulfur-containing gaseous signal molecules, ion channels and cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Ion Channels; Sulfur Dioxide | 2018 |
Redox-Dependent Regulation of Sulfur Metabolism in Biomolecules: Implications for Cardiovascular Health.
Topics: Amino Acids; Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Metabolic Networks and Path | 2019 |
The role of hydrogen sulfide in cyclic nucleotide signaling.
Topics: Animals; Cardiovascular Diseases; Gasotransmitters; Humans; Hydrogen Sulfide; Hypertension; Nucleoti | 2018 |
[Advances in hydrogen sulfide and hydrogen sulfide-releasing drugs].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Central Nervous System Ag | 2016 |
[Role Ofhydrogen Sulfide on Inflammatory Immune Disorders in Cardiovascular Diseases].
Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Immune System Diseases; Inflamma | 2017 |
The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease.
Topics: Cardiovascular Diseases; Drug Development; Humans; Hydrogen Sulfide | 2018 |
Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease.
Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Protein Processing, Post-Translational; | 2018 |
The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.
Topics: Atherosclerosis; Cardiovascular Diseases; Endothelial Cells; Homocysteine; Humans; Hydrogen Sulfide; | 2019 |
Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.
Topics: Cardiovascular Diseases; Humans; Hydrogen Sulfide; Intercellular Signaling Peptides and Proteins; Is | 2019 |
Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Gasotransmitters; Humans; Hydrogen Sulfide; Nitri | 2014 |
Hydrogen sulfide as a potent cardiovascular protective agent.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Humans; Hydrogen Sulfide | 2014 |
Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; China; Humans; Hydrogen Sulfide; Hyperten | 2015 |
Advances in the study on endogenous sulfur dioxide in the cardiovascular system.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Humans; Hydrogen Sulfide; Nitric Oxide; Sul | 2014 |
Chronic low-level hydrogen sulfide exposure and potential effects on human health: a review of the epidemiological evidence.
Topics: Air Pollutants; Cardiovascular Diseases; Dose-Response Relationship, Drug; Epidemiological Monitorin | 2015 |
Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; MicroRNAs; Signal Transduction | 2016 |
Biochemistry and therapeutic potential of hydrogen sulfide - reality or fantasy?
Topics: Animals; Brain; Cardiovascular Diseases; Cysteine; Endothelial Cells; Humans; Hydrogen Sulfide; Mito | 2016 |
Gut Bacteria and Hydrogen Sulfide: The New Old Players in Circulatory System Homeostasis.
Topics: Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Gastrointestinal Microbiom | 2016 |
Amino acids and gaseous signaling.
Topics: Amino Acids; Animals; Carbon Monoxide; Cardiovascular Diseases; Energy Metabolism; Humans; Hydrogen | 2009 |
Significance of endogenous sulphur-containing gases in the cardiovascular system.
Topics: Animals; Cardiovascular Diseases; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Male; Mice; O | 2010 |
[Role of gas signaling molecule hydrogen sulfide in cardiovascular diseases].
Topics: Animals; Cardiovascular Diseases; Coronary Disease; Humans; Hydrogen Sulfide; Hypertension; Hyperten | 2009 |
Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients.
Topics: Cardiovascular Diseases; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Humans; Hydrogen Su | 2010 |
Role of sulfur-containing gaseous substances in the cardiovascular system.
Topics: Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Endothelium; Humans; Hydrogen Sulfi | 2011 |
Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?
Topics: Animals; Cardiovascular Diseases; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Signal Transd | 2012 |
Hydrogen sulfide in cell survival: a double-edged sword.
Topics: Animals; Cardiovascular Diseases; Cell Proliferation; Cell Survival; Cytoprotection; Cytotoxins; Hum | 2011 |
[The role of nitric oxide, hydrogen sulfide and carbon monoxide in the regulation of the circulatory system and their pharmacotherapeutic potential].
Topics: Carbon Monoxide; Cardiovascular Diseases; Cardiovascular System; Coronary Circulation; Humans; Hydro | 2010 |
The role of endogenous H2S in cardiovascular physiology.
Topics: Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Humans; Hydrogen Sulfide; | 2011 |
[A new strategy to treat hyperhomocysteinemia].
Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Metallothionein; T | 2005 |
[Significance of gaseous signal molecule in the pathogenesis of cardiovascular diseases].
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hypertension; Hypertens | 2005 |
Endogenous hydrogen sulfide and the cardiovascular system-what's the smell all about?
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Humans; Hydrogen Sulfide; Nitric Oxide; Pot | 2006 |
Hydrogen sulphide and its therapeutic potential.
Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Inflammation; Motor Activity; Shock, Hem | 2007 |
1 trial available for hydrogen sulfide and Cardiovascular Diseases
| Article | Year |
|---|---|
Improved microvascular reactivity after aged garlic extract intake is not mediated by hydrogen sulfide in older adults at risk for cardiovascular disease: a randomized clinical trial.
Topics: Aged; Cardiovascular Diseases; Garlic; Humans; Hydrogen Sulfide; Male; Microcirculation; Middle Aged | 2022 |
28 other studies available for hydrogen sulfide and Cardiovascular Diseases
| Article | Year |
|---|---|
Pioglitazone treatment increases the cellular acid-labile and protein-bound sulfane sulfur fractions.
Topics: Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Cystathionine gamma-Lyase; Glutathi | 2023 |
Health effects associated with short-term exposure to hydrogen sulfide from geothermal power plants: a case-crossover study in the geothermal areas in Tuscany.
Topics: Aged; Air Pollutants; Cardiovascular Diseases; Emergency Service, Hospital; Environmental Exposure; | 2020 |
Glutathione-Allylsulfur Conjugates as Mesenchymal Stem Cells Stimulating Agents for Potential Applications in Tissue Repair.
Topics: Antioxidants; Biomarkers; Cardiovascular Diseases; Cell Differentiation; Cell Hypoxia; Cell Movement | 2020 |
Reactive Sulfur Species: A New Redox Player in Cardiovascular Pathophysiology.
Topics: Biological Availability; Cardiovascular Diseases; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfid | 2020 |
The Cardiovascular Effects of Hydrogen Sulfide: The Epigenetic Mechanisms.
Topics: Cardiovascular Diseases; Cardiovascular System; Epigenesis, Genetic; Humans; Hydrogen Sulfide; Vasod | 2021 |
Human health cost of hydrogen sulfide air pollution from an oil and gas Field.
Topics: Air Pollutants; Air Pollution; Cardiovascular Diseases; Health Care Costs; Humans; Hydrogen Sulfide; | 2017 |
The pleiotropic effects of hydrogen sulfide.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Gasotransmitters; Hemodynamics; Humans; Hyd | 2018 |
Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease.
Topics: Adult; Aged; Biological Availability; Black or African American; Bridged Bicyclo Compounds; Cardiova | 2018 |
Hydrogen sulfide attenuates oxidative stress-induced NLRP3 inflammasome activation via S-sulfhydrating c-Jun at Cys269 in macrophages.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cell Line; Cysteine; Humans; Hydrogen Peroxide; Hydr | 2018 |
Microvascular circulatory dysregulation driven in part by cystathionine gamma-lyase: A new paradigm for cardiovascular compromise in the preterm newborn.
Topics: Animals; Animals, Newborn; Blood Flow Velocity; Cardiovascular Diseases; Cystathionine gamma-Lyase; | 2019 |
Bioactive Small Molecules in the Pathogenesis and Pharmacology of Cardiovascular Diseases: From Bench to Bedside.
Topics: Antibodies, Monoclonal; Cardiovascular Diseases; Humans; Hydrogen Sulfide; MicroRNAs; Reactive Oxyge | 2018 |
Plasma free H2S levels are elevated in patients with cardiovascular disease.
Topics: Cardiovascular Diseases; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Peripher | 2013 |
Plasma free H2S levels are elevated in patients with cardiovascular disease.
Topics: Cardiovascular Diseases; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Peripher | 2013 |
Plasma free H2S levels are elevated in patients with cardiovascular disease.
Topics: Cardiovascular Diseases; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Peripher | 2013 |
Plasma free H2S levels are elevated in patients with cardiovascular disease.
Topics: Cardiovascular Diseases; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Peripher | 2013 |
Redox regulation of endothelial cell fate.
Topics: Animals; Apoptosis; Cardiovascular Diseases; Cell Cycle; Cell Movement; Cell Transdifferentiation; C | 2014 |
Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway.
Topics: Animals; Cardiovascular Diseases; Hydrogen Sulfide; Hypertension; Liver; Male; NG-Nitroarginine Meth | 2014 |
Anti-inflammatory and cytoprotective properties of hydrogen sulfide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cystathionine beta-Syntha | 2015 |
Vasorelaxant Effect of a New Hydrogen Sulfide-Nitric Oxide Conjugated Donor in Isolated Rat Aortic Rings through cGMP Pathway.
Topics: Animals; Aorta; Carbazoles; Cardiovascular Diseases; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP | 2016 |
Ranking of Molecular Biomarker Interaction with Targeted DNA Nucleobases via Full Atomistic Molecular Dynamics.
Topics: Acetone; Adenine; Biomarkers; Biosensing Techniques; Cardiovascular Diseases; Cytosine; Diabetes Mel | 2016 |
Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetes.
Topics: Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Mellitus, Type 1; | 2008 |
Hydrogen sulfide induces nitric oxide release from nitrite.
Topics: Cardiovascular Diseases; Cardiovascular System; Central Nervous System; Central Nervous System Disea | 2009 |
Frontiers in research series: The pathophysiological significance of sulphur-containing gases. Introduction.
Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Mice; Oxides; Rats; Sulfur Compounds | 2010 |
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Drug Design; Humans; Hydrogen Sulfide; Sign | 2010 |
Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential.
Topics: Animals; Atherosclerosis; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Humans | 2011 |
Adequate hydrogen sulfide, healthy circulation.
Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hypertension; Signal Transduction | 2011 |
H(2)S--the newest gaseous messenger on the block.
Topics: Cardiovascular Diseases; Endothelium, Vascular; Gases; Humans; Hydrogen Sulfide | 2012 |
Hydrogen sulfide in toxication; rapidly transient changes in the electrocardiogram suggestive of myocardial infarction.
Topics: Cardiovascular Diseases; Electrocardiography; Humans; Hydrogen Sulfide; Myocardial Infarction; Poiso | 1954 |
Hydrogen sulfide: from the smell of the past to the mediator of the future?
Topics: Cardiovascular Diseases; Cardiovascular System; Central Nervous System; Central Nervous System Disea | 2003 |
[Hydrogen sulfide: a novel cardiovascular functional regulatory gas factor].
Topics: Animals; Cardiovascular Diseases; Cystathionine gamma-Lyase; Hydrogen Sulfide; Hypertension, Pulmona | 2004 |
Cardiovascular mortality among pulp mill workers.
Topics: Cardiovascular Diseases; Cohort Studies; Coronary Disease; Finland; Humans; Hydrogen Sulfide; Male; | 1990 |